Hemispherx Biopharma to Present at Noble Financial Capital Markets' Annual Equity Conference
16. Mai 2011 12:21 ET
|
Hemispherx Biopharma, Inc.
PHILADELPHIA, May 16, 2011 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) (the "Company" or "Hemispherx") today announced that its Senior Advisor to the CEO, Wayne Pambianchi, will...
Hemispherx Biopharma's Ampligen(R) Cited at Barcelona Vaccine & Active Immunotherapeutics Forum 2011
12. Mai 2011 13:00 ET
|
Hemispherx Biopharma, Inc.
PHILADELPHIA, May 12, 2011 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) (the "Company" or "Hemispherx") today announced that Ampligen® will be featured in a discussion of...
Hemispherx Biopharma Announces Financial Results for the Three Months Ended March 31, 2011
06. Mai 2011 16:55 ET
|
Hemispherx Biopharma, Inc.
PHILADELPHIA, May 6, 2011 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) announced its financial results for the three months ended March 31, 2011. The net loss for the period was...
Animal Model Data Presented at AACR Indicate That Hemispherx Biopharma's Ampligen(R) May be a Potent Tumor Vaccine Adjuvant
04. April 2011 08:00 ET
|
Hemispherx Biopharma, Inc.
PHILADELPHIA, April 4, 2011 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE Amex:HEB) announced new data presented yesterday at the American Association for Cancer Research ("AACR") 102nd Annual...
Hemispherx Biopharma, Inc. to Host 2010 Year End Conference Call on Wednesday, April 6, 2011
31. März 2011 09:56 ET
|
Hemispherx Biopharma, Inc.
PHILADELPHIA, March 31, 2011 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) (the "Company") has scheduled a conference call and audio webcast on Wednesday, April 6, 2011 at 10:00 AM...
Hemisphrex Biopharma Announces Fiscal 2010 Year Results
29. März 2011 13:21 ET
|
Hemispherx Biopharma, Inc.
PHILADELPHIA, March 29, 2011 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE Amex:HEB) announced its financial results for the fiscal year ended December 31, 2010. The net loss for the year (including...
Hemispherx Biopharma Reports on Annual Stockholder Meeting
22. März 2011 14:26 ET
|
Hemispherx Biopharma, Inc.
PHILADELPHIA, March 22, 2011 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE Amex:HEB) announced that it held its 2010 Annual Meeting of Stockholders on March 17, 2011. Final voting results will be...
Hemispherx Biopharma Announces 9th Clinical Investigators Conference: Ampligen Clinical Trials Highlighted
07. März 2011 14:25 ET
|
Hemispherx Biopharma, Inc.
PHILADELPHIA, March 7, 2011 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE:HEB) ("Hemispherx" or the "Company") announced that the Company conducted its 9th Clinical Investigators Conference...
Chronix Biomedical and Hemispherx Biopharma Jointly File Patent Application for a Blood Test for Chronic Fatigue Syndrome (CFS)
03. März 2011 10:00 ET
|
Hemispherx Biopharma, Inc.
Chronix Technology Focuses on Changes to CFS Patients' DNA
Hemispherx and Chronix Plan Studies to Validate Technology as a Potential Diagnostic Test for CFS
SAN JOSE, Calif., March 3, 2011...
Hemispherx Biopharma Annual Meeting Set
24. Februar 2011 08:00 ET
|
Hemispherx Biopharma, Inc.
PHILADELPHIA, Feb. 24, 2011 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) (the "Company") will hold its annual meeting of stockholders on Thursday, March 17, 2011, at 10 a.m. EST, in...